PER 0.00% 8.1¢ percheron therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-31

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 13,692 Posts.
    lightbulb Created with Sketch. 1458
    Akki
    Please answer the Question
    Why did Platinum and AEF invest in Per
    to the tune of $5 million..

    Who is to blame ?
    Why couldn’t Per go directly to a phase 3 in DMD.study
    Spent 4 years eroding shareholder value by designing and developing a phase 3 study Per could not afford.
    Yes ! Thats why my predictions of $1 did not come to fruition.
    This was seen by the current Board and thankfully they adjusted the study to get a readout at the end of 6 months.
    Which in my opinion was the smart thing to do.
    Not only will it alert the FDA but it will attract Big Pharma with the robust data generated…
    So all the negative investors Sell or wait until Nov 24 to be granted substantial ROI.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢
Change
0.000(0.00%)
Mkt cap ! $83.97M
Open High Low Value Volume
8.0¢ 8.1¢ 8.0¢ $61.91K 766.3K

Buyers (Bids)

No. Vol. Price($)
4 549730 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 94626 1
View Market Depth
Last trade - 15.59pm 31/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.